← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Optivia Biotechnology, Inc.
Menlo Park, CA
$4,870,712
Total funding
6
Grants
Funding over time
peak $1.1M · FY2009–15$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,720,712 · 5
FDA$150,000 · 1
By mechanism
R44$3,649,397 · 2
R43$1,221,315 · 4
Investigators at Optivia Biotechnology, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies$924,118
R44 · FY2011 · GM
A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies$923,185
R44 · FY2012 · GM
A Comprehensive Platform to study drug interaction with physiologically important$901,047
R44 · FY2013 · MH
A Comprehensive Platform to study drug interaction with physiologically important$901,047
R44 · FY2014 · MH
A Transporter-Based Predictive ADME Platform$439,346
R43 · FY2010 · RR
Development of A Comprehensive Cell-Based Transporter Assay Platform$406,969
R43 · FY2009 · GM
A novel mechanistic modeling platform for predicting drug clearance and disposition mediated by transporters and enzymes$225,000
R43 · FY2015 · GM
Establishing a comprehensive inhibitory profile of marketed drugs against CNS tra$150,000
R43 · FY2011 · FD